Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States.
Borer JS, Kansal AR, Dorman ED, Krotneva S, Zheng Y, Patel HK, Tavazzi L, Komajda M, Ford I, Böhm M, Kielhorn A.
Borer JS, et al. Among authors: kielhorn a.
J Manag Care Spec Pharm. 2016 Sep;22(9):1064-71. doi: 10.18553/jmcp.2016.22.9.1064.
J Manag Care Spec Pharm. 2016.
PMID: 27579829
Free PMC article.
OBJECTIVE: To estimate the budget impact of ivabradine from a U.S. commercial payer perspective. METHODS: A budget impact model estimated the per-member-per month (PMPM) impact of introducing ivabradine to existing formularies by comparing a reference scenari …
OBJECTIVE: To estimate the budget impact of ivabradine from a U.S. commercial payer perspective. METHODS: A budget impact mode …